8.32
Sensei Biotherapeutics Inc Azioni (SNSE) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
28.43%
5.206
|
7.274 | 7.787 | 8.73 | 8.142 |
Interest Income/Expense |
23.08%
0.01
|
0.013 | 0.024 | 0.028 | 0.031 |
Operating Income/Loss |
28.43%
-5.206
|
-7.274 | -7.787 | -8.73 | -8.142 |
Income/Loss From Continuing Operations Before Tax |
28.09%
-4.936
|
-6.864 | -7.142 | -7.992 | -17.30 |
Income Tax Expense/Benefit |
-
|
- | - | - | -9.89 |
Income/Loss From Continuing Operations After Tax |
28.09%
-4.936
|
-6.864 | -7.142 | -7.992 | -7.414 |
|
28.09%
-4.936
|
-6.864 | -7.142 | -7.992 | -7.414 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
95.00%
1.2609
|
25.19 | 25.10 | 25.05 | -0.9899 |
Diluted Average Shares |
95.00%
1.2609
|
25.19 | 25.10 | 25.05 | -0.9899 |
Basic Earnings Per Share |
1,348%
-3.91
|
-0.27 | -0.28 | -0.32 | -0.30 |
Diluted Earnings Per Share |
1,348%
-3.91
|
-0.27 | -0.28 | -0.32 | -0.30 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):